Dr. Arun Raman, M.B.,B.S. Surgery Medicare: Not Enrolled in Medicare Practice Location: 3100 Ne 28th St, Suite B, Lincoln City, OR 97367 Phone: 541-994-8114 Fax: 541-994-5679 |
Dr. Ali A. Khaki, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 3100 Ne 28th St Ste E, Lincoln City, OR 97367 Phone: 541-994-8114 |
Michael Derek Williams, DO Surgery Medicare: Accepting Medicare Assignments Practice Location: 3100 Ne 28th St Ste E, Lincoln City, OR 97367 Phone: 541-994-8114 Fax: 541-994-5679 |
News Archive
The Children's Legal Centre, based at the University of Essex, has published a report on the Government's 2002 Mental Health Bill which criticises the effect proposals could have on children.
Amgen today announced that the U.S. Food and Drug Administration (FDA) approved two new indications for Prolia® (denosumab) as a treatment to increase bone mass in women at high risk for fracture receiving adjuvant aromatase inhibitor therapy for breast cancer and as a treatment to increase bone mass in men at high risk for fracture receiving androgen deprivation therapy for non-metastatic prostate cancer.
A U.S. district judge in Colorado issued a temporary injunction Friday, blocking the Obama administration from enforcing the birth control coverage requirement on one employer based on the owner's religious beliefs. The judge issued a three-month temporary injunction, allowing for further legal review of the case brought by a small Catholic business owner.
For decades, people seeking an HIV test have been counseled on realistic and achievable steps they could take to avoid infection. But a national study led by Miller School investigators has determined that, given the rapid HIV tests available today, the resources devoted to pre-test counseling would be better spent on universal testing that could detect more HIV cases earlier, and link newly infected people to the treatment that could halt the spread of the virus.
Hanger Orthopedic Group, Inc. announced today the pricing of the previously announced public offering of 2,000,000 shares of its common stock by Ares Corporate Opportunities Fund, L.P. at a public offering price of $20.00 per share. The transaction is expected to close on December 15, 2010. The shares sold were a portion of the currently outstanding shares issued to Ares in August 2008 in connection with the conversion of all of Hanger's Series A Convertible Preferred Stock into common stock.
› Verified 3 days ago